Guardian Pharmacy Services, Inc.
corporate_fare Company Profile
Guardian Pharmacy Services, Inc. (NYSE:GRDN) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 30 items for GRDN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for GRDN spans SCHEDULE 13D/A, 8-K, 10-Q, DEF 14A.
Recent high-impact activity:
- Guardian Pharmacy Lifts FY26 EBITDA Outlook to $136-138M After 24% Q3 EBITDA Growth
- Guardian Pharmacy Class B Converts to Class A, Insider Group Holds 43.9%
- Guardian Pharmacy Acquires Nautilus Assets, Expanding LTC Footprint to 14 States
- Guardian Pharmacy Raises 2026 Guidance After Strong Q2, Net Income Surges on Settlement
- Guardian Pharmacy Services Acquires Wellness Concepts, Expanding Virginia Operations
Financial Snapshot
Short Interest & Short Volume
6.64 days to coverFINRA reported short interest of 2,204,814 shares in GRDN as of the October 30, 2026 settlement, a 7.5% decrease from the prior period — about 6.6 days to cover at its recent average daily volume. On November 20, 2026, 62.0% of GRDN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.